Registration number: 08025133

Medilink South West Limited

(Registration number: 08025133)
Balance Sheet as at 31 March 2026

	2026 £	2025 £
Current assets	15,990	12,176
Creditors: Amounts falling due within one year	(854)	(1,221)
Total assets less current liabilities	15,136	10,955
Accruals and deferred income	(600)	(458)
	14,536	10,497
Capital and reserves	14,536	10,497

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Future Space
Filton Road
Bristol
England
BS34 8RB

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2025 - 0).

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 2 September 2026 and signed on its behalf by:
 

Mr Richard Luxton Director